PEL signed a MoU Canada Pension Plan Investment Board to co-sponsor a renewable energy focused Infrastructure Investment Trust.
Piramal Enterprises Limited (“PEL”) signed a Memorandum of Understanding with Canada Pension Plan Investment Board (“CPPIB”), a Canadian pension fund, to co-sponsor a renewable energy focused Infrastructure Investment Trust (“InvIT”). With an initial corpus of US$ 600 million, and the option to scale further, the InvIT would seek to acquire up to 1.5-2GW of stable and cash generating renewables assets on a hold-to-maturity basis, with a firm focus on diversification of both asset type as well as off-taker profile.
Ajay Piramal, Chairman, Piramal Group, said “We are pleased to partner with CPPIB on the launch of the first ever InvIT in India, focused on renewables. The foundation of this partnership is based on a shared ethos and values that leverage CPPIB’s global track record of value creation in the infrastructure space with PEL’s long term strategy and goodwill in India. We are enthusiastic about the opportunity as it is truly scalable andcontinue to remain committed to creating value for our shareholders.”
Both PEL and CPPIB will act as Co-Sponsors of the proposed InvIT and hold up to 75% of the units (withCPPIB committing US$360m and holding up to 60%; PEL committing US$90m and holding 15% ) and seek to raise capital from other like-minded investors for the remaining 25%. In the interim and prior to its launch,PEL and CPPIB will jointly warehouse seed assets for the proposed InvIT.PEL would act as the sole Investment Manager as well as Project Manager for the proposed InvIT.
Piramal further added, “The renewable energy sector is at an inflection point and is witnessing significant consolidation, the pace of which is likely to increase in the near future. We believe that the timing is therefore opportune for aggregating assets in this sector given that the existing players are willing sellers in light of a constrained capital market environment – both debt and equity. This is the first truly neutral ‘white-label’ InvIT – led by a fiduciary and supported by patient capital and strong corporate governance – that we believe, can serve as a strong catalyst for the sector as a whole.”